Latest news
146 Giredestrant Vs Standard-of-Care Endocrine Therapy as Adjuvant Treatment for Patients With Estrogen Receptor–Positive, HER2-Negative Early Breast Cancer: Results From the Global Phase III lidERA Breast Cancer Trial - CancerNetworkCancerNetwork · Sat, 08 Aug 2026 14:00:00 GMTElizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab - Urology TimesUrology Times · Fri, 07 Aug 2026 17:34:09 GMTAMH Levels May Predict Adjuvant Chemotherapy Benefit in Premenopausal Women With Breast Cancer - The ASCO PostThe ASCO Post · Fri, 07 Aug 2026 15:35:11 GMTLibtayo® (cemiplimab for injection) Receives Health Canada Approval for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma - PR Newswire CanadaPR Newswire Canada · Thu, 06 Aug 2026 15:30:00 GMTFusobacterium Positivity May Predict Relapse Risk, Benefit From Adjuvant Chemotherapy in Colorectal Cancer - The ASCO PostThe ASCO Post · Thu, 06 Aug 2026 14:55:44 GMTAdjuvant Therapy in Renal Cell Carcinoma: Who Benefits and Who Is Overtreated - OncodailyOncodaily · Mon, 03 Aug 2026 13:22:10 GMT